Related references
Note: Only part of the references are listed.Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19
Jonathan T. Sims et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms
Anna Santaella et al.
BMC NEUROLOGY (2020)
Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage
Fuyou Guo et al.
FASEB JOURNAL (2020)
Host engulfment pathway controls inflammation in inflammatory bowel disease
Ibrahim M. Sayed et al.
FEBS JOURNAL (2020)
Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis
Maho Suzukawa et al.
JOURNAL OF INFECTION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications
Ibrahim Kalle Kwaifa et al.
BIOMOLECULES (2020)
Upregulated C-C Motif Chemokine Ligand 2 Promotes Ischemic Stroke via Chemokine Signaling Pathway
Lin Li et al.
ANNALS OF VASCULAR SURGERY (2020)
Diagnostic potential of urinary monocyte chemoattractant protein-1 for Alzheimer's disease and amnestic mild cognitive impairment
Y. Xu et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy
Aurelie Joly-Amado et al.
FRONTIERS IN IMMUNOLOGY (2020)
IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2
Hossam Taha Mohamed et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss
Yaqian Hu et al.
MOLECULAR MEDICINE REPORTS (2020)
IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
Sujin Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Association of Early Nasopharyngeal Immune Markers With COVID-19 Clinical Outcome: Predictive Value of CCL2/MCP-1
Beatriz Sierra et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson's disease
Anna Santaella et al.
NPJ PARKINSONS DISEASE (2020)
Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma
Ju-Fang Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
Marthe Jontvedt Jorgensen et al.
SCIENTIFIC REPORTS (2020)
IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
Yu Chen et al.
MOLECULAR MEDICINE (2020)
The Significance of HCV Viral Load in the Incidence of HCC: a Correlation Between Mir-122 and CCL2
Heba K. Nabih
JOURNAL OF GASTROINTESTINAL CANCER (2020)
Elevated circulating T cell subsets and cytokines expression in patients with rheumatoid arthritis
Haiyan Zhou et al.
CLINICAL RHEUMATOLOGY (2019)
Increases in a Pro-inflammatory Chemokine, MCP-1, Are Related to Decreases in Memory Over Time
Brianne M. Bettcher et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
Laura Fantuzzi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Inflammatory molecules produced by meniscus and synovium in early and end-stage osteoarthritis: a coculture study
Marta Favero et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection
Jie Lu et al.
JOURNAL OF INFECTION (2019)
Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations
Yousof Taghavi et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2019)
Protective Effect of the MCP-1 Gene Haplotype against Schizophrenia
Hana Saoud et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Association between MCP-1-2518A>G polymorphism and asthma susceptibility: a meta-analysis
Wenli Chen et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2019)
Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease
Akio Kimura et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
Pranabananda Dutta et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Insulin resistance causes inflammation in adipose tissue
Mitsugu Shimobayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats
Yungong Wang et al.
MOLECULAR PAIN (2018)
Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
Wei-Ju Lee et al.
SCIENTIFIC REPORTS (2018)
Blood MCP-I levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema
Antonino Di Stefano et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders
Sara Hall et al.
SCIENTIFIC REPORTS (2018)
CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis
Harini Raghu et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Urinary MCP-1 as a biomarker for lupus nephritis: a meta-analysis
Y. H. Lee et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2017)
Aronia melanocarpa (Black Chokeberry) Reduces Ethanol-Induced Gastric Damage via Regulation of HSP-70, NF-κB, and MCP-1 Signaling
Antonisamy Paulrayer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus
Dai-Shi Tian et al.
JOURNAL OF NEUROSCIENCE (2017)
Monocyte Chemoattractant Protein-1 (MCP-1) as a Potential Therapeutic Target and a Noninvasive Biomarker of Liver Fibrosis Associated With Transient Myeloproliferative Disorder in Down Syndrome
Kenichiro Kobayashi et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
The MCP-4/MCP-1 ratio in plasma is a candidate circadian biomarker for chronic post-traumatic stress disorder
C. Dalgard et al.
TRANSLATIONAL PSYCHIATRY (2017)
Investigation of the prognostic value of adipokines in multiple sclerosis
Arzu Coban et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
A functional SNP MCP-1 (-2518A/G) predispose to renal disorder in Indian Systemic Lupus Erythematosus patients
Vinod D. Umare et al.
CYTOKINE (2017)
Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model
Taryn L. Cranford et al.
CANCER BIOLOGY & THERAPY (2017)
Roles of monocyte chemotactic protein 1 and nuclear factor-κB in immune response to spinal tuberculosis in a New Zealand white rabbit model
X. H. Guo et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2017)
Monocytes and monocyte chemoattractant protein 1 (MCP-1) as early predictors of disease outcome in patients with cerebral ischemic stroke
David Bonifacic et al.
WIENER KLINISCHE WOCHENSCHRIFT (2016)
Chemokine and cytokine levels in inflammatory bowel disease patients
Udai P. Singh et al.
CYTOKINE (2016)
Oxidative damage induces MCP-1 secretion and macrophage aggregation in age-related macular degeneration (AMD)
Zhaojiang Du et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2016)
Higher expression of monocyte chemoattractant protein 1 and its receptor in brain tissue of intractable epilepsy patients
Chunyan Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
The Chemokine CCL2 Mediates the Seizure-enhancing Effects of Systemic Inflammation
Chiara Cerri et al.
JOURNAL OF NEUROSCIENCE (2016)
Monocyte chemoattractant protein 1 and macrophage migration inhibitory factor in children with type 1 diabetes
Nagwa Abdallah Ismail et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2016)
Role of neuroinflammation in neurodegenerative diseases
Wei-Wei Chen et al.
MOLECULAR MEDICINE REPORTS (2016)
Induction of IL-8(CXCL8) and MCP-1(CCL2) with oxidative stress and its inhibition with N-acetyl cysteine (NAC) in cell culture model using HK-2 cell
Avneesh Kumar et al.
TRANSPLANT IMMUNOLOGY (2016)
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet
Lin Yan et al.
ONCOTARGET (2016)
Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage ColonyStimulating Factor by Breast Cancer Cells
Teizo Yoshimura et al.
FRONTIERS IN IMMUNOLOGY (2016)
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Dipak P. Ramji et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
The-A2518G polymorphism in the MCP-1 gene and inflammatory bowel disease risk: A meta-analysis
Yu Wen Li et al.
JOURNAL OF DIGESTIVE DISEASES (2015)
Adipocyte-Derived Monocyte Chemotactic Protein-1 (MCP-1) Promotes Prostate Cancer Progression Through the Induction of MMP-2 Activity
Yusuke Ito et al.
PROSTATE (2015)
Chemokine Signaling Pathway Involved in CCL2 Expression in Patients with Rheumatoid Arthritis
Lin Zhang et al.
YONSEI MEDICAL JOURNAL (2015)
Reduction in Disease Progression by Inhibition of Transforming Growth Factor α-CCL2 Signaling in Experimental Posttraumatic Osteoarthritis
C. Thomas G. Appleton et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer
Li Li et al.
TUMOR BIOLOGY (2015)
The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis
Yuan-kun Xu et al.
BIOLOGICAL RESEARCH (2015)
Inflammatory dysregulation of blood monocytes in Parkinson's disease patients
Veselin Grozdanov et al.
ACTA NEUROPATHOLOGICA (2014)
Impact of MCP-1 in Atherosclerosis
Juntang Lin et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus
A. W. Wahid Ansari et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Monocyte Chemotactic Protein 1 (MCP-1) Modulates Pro-Survival Signaling to Promote Progression of Head and Neck Squamous Cell Carcinoma
Wen-Tsai Ji et al.
PLOS ONE (2014)
Pro-Inflammatory Chemokine CCL2 (MCP-1) Promotes Healing in Diabetic Wounds by Restoring the Macrophage Response
Stephen Wood et al.
PLOS ONE (2014)
Investigation of serum macrophage migration inhibitor factor and monocyte chemotactic protein-1 levels in irritable bowel syndrome
Feti Tulubas et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2014)
Non-myeloid cells are major contributors to innate immune responses via production of monocyte chemoattractant protein-1/CCL2
Teizo Yoshimura et al.
FRONTIERS IN IMMUNOLOGY (2014)
Endothelial dysfunction - A major mediator of diabetic vascular disease
Cristina M. Sena et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment
Daniel Lindqvist et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells
Teizo Yoshimura et al.
PLOS ONE (2013)
Monocyte Chemoattractant Protein-1 Deficiency Attenuates Oxidative Stress and Protects against Ovariectomy-Induced Chronic Inflammation in Mice
Woon-Ki Kim et al.
PLOS ONE (2013)
The CCL2-CCR2 system affects the progression and clearance of intracerebral hemorrhage
Yao Yao et al.
GLIA (2012)
Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation
Ok-Joo Sul et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
MCP-1 and CCR2 gene variants in oral squamous cell carcinoma
K. Bektas-Kayhan et al.
ORAL DISEASES (2012)
CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis
Rachel E. Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Upregulation of Retinal Neuronal MCP-1 in the Rodent Model of Diabetic Retinopathy and Its Function In Vitro
Ning Dong et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Chemokines in CSF of Alzheimer's disease patients
Joice Dias Correa et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2011)
Chemokine (C-C Motif) Ligand 2 (CCL2) in Sera of Patients with Type 1 Diabetes and Diabetic Complications
Ruili Guan et al.
PLOS ONE (2011)
Indoxyl Sulfate Upregulates Expression of ICAM-1 and MCP-1 by Oxidative Stress-Induced NF-kappa B Activation
Zohra Tumur et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Critical Protective Role for MCP-1 in Pneumonic Burkholderia mallei Infection
Andrew Goodyear et al.
JOURNAL OF IMMUNOLOGY (2010)
Persistent Chronic Inflammation and Infection by Chikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response
Jean-Jacques Hoarau et al.
JOURNAL OF IMMUNOLOGY (2010)
Monocyte Chemoattractant Protein-1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease
Anna Sokolova et al.
BRAIN PATHOLOGY (2009)
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
Yi Lu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Satish L. Deshmane et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis
Zahra Hasan et al.
PLOS ONE (2009)
MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus
Guadalupe Lima et al.
HUMAN IMMUNOLOGY (2007)
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia
Mark C. Dessing et al.
CLINICAL IMMUNOLOGY (2007)
Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells
R. M. Dwyer et al.
CLINICAL CANCER RESEARCH (2007)
IFN-γ-Mediated survival enables human Neutrophils to produce MCP-1/CCL2 in response to activation by TLR Ligands
Teizo Yoshimura et al.
JOURNAL OF IMMUNOLOGY (2007)
Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis
Maritta Ukkonen et al.
MULTIPLE SCLEROSIS (2007)
CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration
Robert D. Loberg et al.
NEOPLASIA (2007)
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice
Elena Zamara et al.
JOURNAL OF HEPATOLOGY (2007)
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease
Daniela Galimberti et al.
NEUROBIOLOGY OF AGING (2006)
Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells
W. I. Khan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis
Naoyuki Tanuma et al.
ACTA NEUROPATHOLOGICA (2006)
Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy
Kohzo Takebayashi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
MCP-1-stimulated chemotaxis of monocytic and endothelial cells is dependent on activation of different signaling cascades
TI Arefieva et al.
CYTOKINE (2005)
MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels
C Fenoglio et al.
NEUROBIOLOGY OF AGING (2004)
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus
N Koide et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Polymorphisms of chemokine and chemokine receptor genes in type 1 diabetes mellitus and its complications
B Yang et al.
CYTOKINE (2004)
Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells
S Futagami et al.
GUT (2003)
Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy
JS Lee et al.
INFLAMMATION RESEARCH (2003)
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy
T Morii et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2003)
Monocyte chemoattractant protein-1 selectively inhibits, the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response
N Omata et al.
JOURNAL OF IMMUNOLOGY (2002)
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes
F Chiarelli et al.
DIABETES CARE (2002)
Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity
TR Traynor et al.
JOURNAL OF IMMUNOLOGY (2002)
IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease
E Scarpini et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
Interaction between chemokines and oxidative stress:: Possible pathogenic role in acute coronary syndromes
P Aukrust et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
Share Paper
